Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Ambys Medicines opens cell therapy manufacturing facility, presents data on liver cell data

By Brian Buntz | September 27, 2021

Ambys MedicinesPrivately-held Ambys Medicines has announced that it has opened a 52,000-ft² facility dedicated to hepatocyte manufacturing. The facility is certified to current Good Manufacturing Practices (cGMP) regulations.

The company, based in South San Francisco, California, also presented data on its novel bioreactor manufacturing at the Joint Congress of the International Xenotransplantation Association, IXA-CTRMS-2021.

Focused on developing novel treatments of severe liver disease, Ambys says it expects its lead program to enter the clinic in early 2023.

“The concept of hepatocyte transplantation with donor cells has been explored in academic settings for over 20 years,” said Dr. Ron Park, CEO of Ambys Medicines, in a statement. “These past efforts showed that mature hepatocytes were active and that the approach was safe, but further progress has been limited by the inability to generate adequate quantities of high-quality hepatocytes sufficient to drive clinical benefit.”

Launched in 2018 with $140 million in initial funding, Ambys has received initial funding from VCs and Osaka, Japan–based Takeda (NYSE:TAK).

 

 


Filed Under: Biospecimens, Drug Discovery and Development, Hepatology
Tagged With: Ambys Medicines, bioreactor, cGMP, liver disease
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Dr. Brad Perkins, Chief Medical Officer at Karius, details how the company aims to transform the diagnosis of infections
How Karius aims to transform the diagnosis of infections with a non-invasive liquid biopsy
Bio-Rad
Bio-Rad debuts anti-cemiplimab antibodies
Lunaphore
How Lunaphore aims to simplify spatial biology
Berkeley Lights
Berkeley Lights names new CEO

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50